At a glance
ClinicalIndex Comparison RecordN/ACompleted· 154 enrolled
Drug / intervention
ClearSight Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Noninvasive Continuous Blood Pressure Monitoring for Preventing Post-spinal Hypotension During Cesarean Delivery: A Randomized Controlled Trial
In Brief
A clinical study evaluating ClearSight System for Cesarean Section Complications and Hypotension. Completed, enrolled 154 participants across 1 site.
Detailed Summary
Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCesarean Section Complications, Hypotension
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartApr 2021
Primary CompletionOct 2022
Study CompletionDec 2022
TodayJul 2026
First PostedFeb 12, 2021
Enrollment StartApr 27, 2021
Primary CompletionOct 26, 2022
Study CompletionDec 21, 2022
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.4 years ago
Interventions
ClearSight Systemdevice
Non-invasive, continuous blood pressure is monitored using ClearSight Sytem